Literature DB >> 24565453

Management of difficult-to-treat atopic dermatitis.

Peter D Arkwright1, Cassim Motala2, Hamsa Subramanian3, Jonathan Spergel4, Lynda C Schneider5, Andreas Wollenberg6.   

Abstract

Atopic dermatitis is a complex disorder caused by the interplay between multiple genetic and environmental factors. Particularly in patients with severe disease, the effect is not just an itchy rash but also the secondary effects on the psychological well-being of the patient and their carers, particularly disturbed sleep. The aim of this review is to provide health care professionals with a holistic approach to the management of difficult-to-treat atopic dermatitis, defined as atopic dermatitis seemingly unresponsive to simple moisturizers and mild potency (classes VI and VII) topical corticosteroids. The critical importance of education and advice is emphasized, as is the seminal role of secondary bacterial infection and polyclonal T-cell activation in causing acute flares in patients with severe, generalized disease. In atypical cases or those that do not respond to treatment, alternative diagnoses should be considered.
Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atopic dermatitis; Compliance; Corticosteroids; Cyclosporine; Eczema; Review; Tacrolimus

Mesh:

Substances:

Year:  2012        PMID: 24565453     DOI: 10.1016/j.jaip.2012.09.002

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  37 in total

Review 1.  Treatment of Eczema: Corticosteroids and Beyond.

Authors:  Melanie Chong; Luz Fonacier
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

Review 2.  Atopic dermatitis in children: clinical features, pathophysiology, and treatment.

Authors:  Jonathan J Lyons; Joshua D Milner; Kelly D Stone
Journal:  Immunol Allergy Clin North Am       Date:  2014-11-21       Impact factor: 3.479

Review 3.  Topical corticosteroid-induced skin atrophy: a comprehensive review.

Authors:  Laurent Barnes; Gurkan Kaya; Victoria Rollason
Journal:  Drug Saf       Date:  2015-05       Impact factor: 5.606

4.  In Vitro Modeling of Skin Barrier Disruption and its Recovery by Ceramide-Based Formulations.

Authors:  Barbora Amélie Čuříková-Kindlová; Aneta Vovesná; Anna Nováčková; Jarmila Zbytovská
Journal:  AAPS PharmSciTech       Date:  2021-12-14       Impact factor: 3.246

5.  Potential treatment of atopic dermatitis: tolerability and safety of cream containing nanoparticles loaded with hydrocortisone and hydroxytyrosol in human subjects.

Authors:  Muhammad Irfan Siddique; Haliza Katas; Adawiyah Jamil; Mohd Cairul Iqbal Mohd Amin; Shiow-Fern Ng; Mohd Hanif Zulfakar; Syed Maaz Nadeem
Journal:  Drug Deliv Transl Res       Date:  2019-04       Impact factor: 4.617

Review 6.  [Topical therapy for atopic eczema].

Authors:  M Knop; A Gürtler; A Heratizadeh; N Aszodi; Th Werfel; A Wollenberg
Journal:  Hautarzt       Date:  2018-03       Impact factor: 0.751

Review 7.  [New aspects in systemic treatment of atopic dermatitis].

Authors:  T Werfel; A Wollenberg; T Pumnea; A Heratizadeh
Journal:  Hautarzt       Date:  2018-03       Impact factor: 0.751

Review 8.  Emollients and moisturisers for eczema.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Robin Christensen; Adriana Lavrijsen; Bernd WM Arents
Journal:  Cochrane Database Syst Rev       Date:  2017-02-06

Review 9.  Clinical approach to the patient with refractory atopic dermatitis.

Authors:  Neema Izadi; Donald Y M Leung
Journal:  Ann Allergy Asthma Immunol       Date:  2018-01       Impact factor: 6.347

10.  Young adults' perceptions of living with atopic dermatitis in relation to the concept of self-management: a qualitative study.

Authors:  Susanne Lundin; Marina Jonsson; Carl-Fredrik Wahlgren; Emma Johansson; Anna Bergstrom; Inger Kull
Journal:  BMJ Open       Date:  2021-06-23       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.